CINP is pleased to announce that in 2020 the Ethics Prize in Psychopharmacology will be presented at the 32nd World Congress in parallel with the other international CINP-sponsored awards. The Ethics Prize in Psychopharmacology will recognise an individual’s outstanding achievements in ethics research within the field of psychopharmacology as well as their contribution to the promotion of public awareness of ethics in psychopharmacology and contributions to the world-wide solution of issues and questions within the ethical practice of psychopharmacology. While the subject of ethics involves all of human behaviour; ethics within medicine and medical research, particularly within the field of psychopharmacology, raises numerous sensitive issues related to the very essence of human nature.
Areas of consideration
1) Ethics of scientific responsibility in publishing in psychopharmacology
2) Conflict of interest in clinical research
3) Treatment of research subjects both human and animal
4) Informed consent in psychopharmacology research
5) Doctor patient relationships in psychopharmacology
Applicants must be nominated by a CINP member, include a CV and one to three-page statement of the justification of the nomination. Applications to this award will be judged by the Ethics Committee, an international committee of experts in the field. All submissions should be received by Thursday, February 6, 2020.